Pharmafile Logo
Pharmafocus logo
Advanced Search

Spend NHS surplus on out-of-hours, say primary care leaders

March 14, 2008

Primary care leaders have called for some of the predicted billions in the NHS budget surplus to be spent on …

News

Workshops to bring together industry and NHS researchers

March 14, 2008
ABPI

The pharma industry and interested NHS researchers will come together in a new initiative aimed at increasing and accelerating clinical …

News

Why should we listen to you?

March 12, 2008
Medical Communications, Sales and Marketing industry relations, marketing, stakeholders

Last month, Pharmafocus showed how market access can be a platform to build a cohesive strategy that brings together sales, …

Feature

Latest news from Datamonitor

March 12, 2008
Sales and Marketing

Type 2 diabetes driving epidemic Type 2 diabetes poses one of the greatest public health threats of the 21st century. …

News

Abbott to work on Tarceva diagnostic

March 12, 2008
Sales and Marketing

Abbott is to develop a diagnostic test for Tarceva to identify patients who could most benefit from the lung cancer …

News

Lilly decision spells end for inhaled insulin

March 12, 2008
Research and Development

Regulatory problems and doubts about commercial potential have led Lilly to abandon its late-stage inhaled insulin product. The AIR insulin …

News

Putting UK pharma centre stage

March 7, 2008
Research and Development, Sales and Marketing innovation, pharma

Feature

New laws will oblige pharma to release data

March 7, 2008
Sales and Marketing

The UK government has pledged to introduce new legislation that will require pharmaceutical companies to disclose all data from clinical …

News

GPs reluctantly agree to extend hours

March 7, 2008

General practitioners across the UK have voted to accept new working hours that will see surgeries open on Saturday mornings …

News

Efexor successor approved in US

March 7, 2008
Sales and Marketing

Wyeth's Pristiq, a refined version of its top-selling depression treatment Efexor, has been approved in the US. Pristiq (desvenlafaxine) delivers …

News

Renovo wounded by cosmetic drug setback

March 7, 2008
Research and Development, Sales and Marketing

UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …

News

Frontline doctor to lead UK diabetes strategy

March 7, 2008

Dr Rowan Hillson has been appointed the new national clinical director for diabetes. Dr Hillson is a consultant physician and …

News

NICE’s approach to benefits and costs to be reviewed

March 7, 2008
Sales and Marketing

The pharmaceutical industry has welcomed plans to review how NICE assesses the benefits and costs of drugs, with the hope …

News

Diabetes nurses would cut emergency admissions

March 7, 2008
Sales and Marketing

Specialist nurses could help to cut the number of diabetes patients being admitted to hospital as emergency cases, a new …

News

Latest news from Datamonitor

March 5, 2008
Sales and Marketing

APP Pharma granted approval for generic anticancer drug APP Pharmaceuticals has received final approval from the FDA of its abbreviated …

News

GSK abandons malaria drugs

March 4, 2008
Sales and Marketing reg, safety

News

Government remains tight-lipped on PPRS

February 29, 2008
Sales and Marketing par

The Department of Health has refused to comment on renewed speculation on the future of the UK's medicines pricing system …

News

FDA rejects long-acting version of Zyprexa

February 29, 2008
Sales and Marketing

Lilly has suffered a setback after the US medicines regulator rejected a new version of its top-selling product Zyprexa. The …

News

Working with NICE: the ingredients for success

February 29, 2008
Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma

NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …

Feature

Avastin receives surprise FDA approval

February 29, 2008
Sales and Marketing

The FDA gone against the advice of its own advisory panel to approve Genentech's Avastin as a first-line treatment for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025